BlackRock Fund Advisors - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 14 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2016$867,000
+28.4%
102,550
+3.1%
0.00%
Q3 2016$675,000
+168.9%
99,448
+18.4%
0.00%
Q2 2016$251,000
+169.9%
83,962
+63.5%
0.00%
Q1 2016$93,000
+3.3%
51,368
-6.2%
0.00%
Q4 2015$90,000
+12.5%
54,790
+7.4%
0.00%
Q3 2015$80,000
-50.3%
51,004
-2.6%
0.00%
Q2 2015$161,00052,3540.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2015
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,563,925$16,717,00029.31%
Cormorant Asset Management, LP 2,000,000$13,580,0001.50%
Perceptive Advisors 2,701,023$18,339,0001.18%
Fosun International Ltd 700,071$4,753,0000.53%
Ghost Tree Capital, LLC 200,000$1,358,0000.22%
ACUTA CAPITAL PARTNERS, LLC 81,302$552,0000.21%
IFP Advisors, Inc 300,000$2,037,0000.11%
CONNING INC. 351,280$2,385,0000.10%
WOODSTOCK CORP 39,931$271,0000.06%
Yellowstone Partners, LLC 15,944$108,0000.04%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders